Trilostane

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTrilostane
Drug Alias Name曲洛司坦trilostanotrilostanumWin-25540
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors antagonists
TargetsEstrogen receptors
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsProstatic Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1984/12/31
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesStegram
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioenvision Ltd
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeH02CA01
Related LinksWikipediaDrugBankKEGG